Scarica l'app Stockscreener
64.68
0.84%
0.54
Dopo l'orario di chiusura:
64.70
0.02
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$64.14
Aprire:
$63.87
Volume 24 ore:
2.00M
Relative Volume:
1.04
Capitalizzazione di mercato:
$31.54B
Reddito:
$10.63B
Utile/perdita netta:
$819.00M
Rapporto P/E:
39.02
EPS:
1.6577
Flusso di cassa netto:
$1.59B
1 W Prestazione:
-2.75%
1M Prestazione:
-1.96%
6M Prestazione:
-18.64%
1 anno Prestazione:
-23.70%
Intervallo 1D:
$63.84
$64.92
Intervallo di 1 settimana:
$63.81
$68.02
Portata 52W:
$61.84
$92.55
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
64.68 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
406.78 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
143.98 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
35.94 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
188.63 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Iniziato | William Blair | Mkt Perform |
| 2026-01-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Downgrade | Stifel | Buy → Hold |
| 2025-12-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
Alcon StockWeekly review and sector comparison - AD HOC NEWS
Soft start into silicone hydrogel, Alcon’s PRECISION1 daily lens aims for easy wearers - AD HOC NEWS
Why Alcon’s SYSTANE Hydration PF has become a quiet everyday essential - AD HOC NEWS
Alcon AG (ALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
New contact lens comfort data puts Alcon’s DAILIES TOTAL1 center stage - AD HOC NEWS
Alcon launches Unity CS cataract surgery system in Canada - Investing.com UK
New treatment option for cataract surgeons, Alcon Clareon IOL expands premium lineup - AD HOC NEWS
Canadian launch sets the stage for Alcon’s UNITY CS cataract system - AD HOC NEWS
Alcon Inc Stock (CH0432492467): Eye-care leader in focus after recent trading and sector moves - AD HOC NEWS
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada - Eagle-Tribune
Alcon Inc. (ALC) Stock Analysis: Eyeing A 31.52% Potential Upside In The Healthcare Market - DirectorsTalk Interviews
Alcon Inc. Stock (CH0432492467): Ownership changes put the eye-care group in focus - AD HOC NEWS
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Alcon Inc. Stock (CH0432492467): Valuation metrics keep eye-care leader in focus - AD HOC NEWS
Alcon Inc Stock (CH0432492467): Citi reiterates Buy rating and sees upside potential - AD HOC NEWS
Alcon DAILIES TOTAL1 contact lenses: daily comfort for dry-eye wearers - AD HOC NEWS
KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $88 - Moomoo
Alcon (ALC) Gets a Buy from Citi - The Globe and Mail
Citi Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $103 - Moomoo
Alcon Inc Stock (CH0432492467): Analyst targets highlight upside after Q1 update - AD HOC NEWS
Systane class action claims eye drops falsely advertised as preservative-free - Class Action Lawsuits
Alcon Inc. stock (CH0432492467): eye-care specialist steadies after Q1 2026 update - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist steadies after Q1 earnings and dividend update - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after recent earnings and outlook - AD HOC NEWS
Alcon Inc. stock (CH0432492467): eye-care specialist edges higher after Q1 earnings and guidance upd - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Eye-care specialist builds on Q1 earnings momentum - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after recent earnings update - AD HOC NEWS
BTIG lowers Alcon stock price target to $82 on lower valuation - Investing.com
Alcon faces class-action lawsuit over false product marketing - Eyes On Eyecare
Alcon shares see BofA reiterate underperform on soft Q1 results - Investing.com
Alcon Q1 2026 slides: EPS beats but revenue miss sparks selloff - Investing.com
Alcon Inc stock (CH0432492467): shares steady after Q1 2026 earnings beat and raised guidance - AD HOC NEWS
Swiss eye care firm Alcon's quarterly revenue rises less than expected - marketscreener.com
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued - GuruFocus
Alcon Inc stock (CH0432492467): sector backdrop in focus as shares consolidate - AD HOC NEWS
Alcon Inc. stock (CH0432492467): shares hover in mid-60 USD range on NYSE as investors await next ea - AD HOC NEWS
Alcon Inc. stock (CH0432492467): shares near mid-60 USD range ahead of next earnings update - AD HOC NEWS
Recalled Systane, GenTeal Tears Eye Products Falsely Labeled as ‘Sterile’ Despite Contamination Risks, Class Action Claims - ClassAction.org
Alcon Inc. (ALC) Stock Analysis: Eyeing a 33.54% Potential Upside in the Growing Healthcare Sector - DirectorsTalk Interviews
Alcon Inc stock (CH0432492467): Shares steady as investors digest Q1 2026 results and eye care marke - AD HOC NEWS
Alcon: Product Cycle Reset Creates An Attractive Entry Point (Initiating Buy) (NYSE:ALC) - Seeking Alpha
Alcon Inc. stock (CH0432492467): shares steady as Swiss eye-care group trades near recent highs - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group holds near USD mid-60s as investors track valuation m - AD HOC NEWS
Alcon Inc. stock (CH0432492467): steady trading ahead of next catalysts and valuation focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Swiss-listed shares slip in line with market - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group steady as investors watch sector trends - AD HOC NEWS
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - TradingView
Alcon stock: Earnings, guidance and lens demand in focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings and guidance upda - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after latest earnings - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings update - AD HOC NEWS
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
1.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):